News
Food and Drug Administration Commissioner Dr. Marty Makary joins 'Fox & Friends Weekend' to discuss the MAHA push as major ...
US Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether a gene therapy from ...
2d
News Nation on MSNFDA chief: HRT warning among ‘greatest mistakes of modern medicine’( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the ...
The FDA is targeting ultraprocessed foods for reform to improve healthfulness of children's food. Whether the approach is comprehensive remains to be seen.
FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
2d
MedPage Today on MSNRemove Boxed Warning on Hormone Therapy for Menopause, FDA Panel SaysA panel selected by FDA Commissioner Marty Makary, MD, MPH, unanimously urged the agency to remove the boxed warning on ...
9don MSNOpinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...
10h
The Western Journal on MSNGood News for Ice Cream Lovers: Key Manufacturers Make Big Health Vow Targeting 2028Robert F. Kennedy Jr.'s strategy as head of the Department of Health and Human Services is bearing fruit with regard to ice cream as various federal agencies announce that International Dairy Foods ...
3d
Agence France-Presse on MSNUS may revise hormone replacement therapy warningsUS Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...
3d
MedPage Today on MSNA 'Culture Change' Is Needed in Academic Medicine, FDA Commissioner SaysThe culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...
2d
Asianet Newsable on MSNFDA Is Reportedly ‘Taking A Hard Look’ To Evaluate Whether Sarepta’s Gene Therapy Elevidys Should Remain On The MarketThe growing number of fatalities is raising questions about the future of Sarepta’s therapies and the regulatory path for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results